Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnAISquareMore
Boreal Gold reports 190.38 g/t gold from Koscielny Lake trench on Fay Lake property

Boreal Gold reports 190.38 g/t gold from Koscielny Lake trench on Fay Lake property

ReutersReuters2026/09/14 13:31
  • Boreal Gold reported high-grade surface grab-sample results from the Fay Lake property in Manitoba, dated Sept. 14, 2026.
  • Koscielny Lake trench 7 (Lakeshore Vein) returned a top assay of 190.38 g/t gold; 10 of 11 samples exceeded 1 g/t.
  • Redwin Shaft area grab samples returned up to 19.19 g/t gold, with elevated copper reported alongside slightly higher zinc.
  • Three NQ diamond drill holes at Koscielny Lake and three at Redwin were completed; core is being processed for lab assays.
  • Winter 2027 drilling is planned to test the Lakeshore Vein from lake ice, targeting follow-up on higher-grade trench results.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Boreal Gold Inc. published the original content used to generate this news brief via Newsfile (Ref. ID: 202609140931NEWSFILECNPR____20260914_314174_1) on September 14, 2026, and is solely responsible for the information contained therein.

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Competition in US oral weight-loss drugs intensifies! Eli Lilly (LLY.US) Foundayo captures 30% of new patients, narrowing Novo Nordisk's (NVO.US) first-mover advantage

Eli Lilly stated on Monday that its oral weight-loss drug, Foundayo, has captured over 30% of the market share among new patients in the US oral obesity treatment market, narrowing the early lead achieved by Danish competitor Novo Nordisk with its Wegovy oral tablets.

智通财经2026/09/15 03:21
Competition in US oral weight-loss drugs intensifies! Eli Lilly (LLY.US) Foundayo captures 30% of new patients, narrowing Novo Nordisk's (NVO.US) first-mover advantage